However, while Demiroz et al. reported no significant association for the SII, our study found that the SII plays a critical role in fibrosis progression in MASLD, especially when correlated with other markers such as the CAR and IL-17A [32]. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatotic liver disease.